The most recent ESC/EAS recommendations [9] and the position of the EAS experts [264] on HoFH did not significantly change the position on this issue, while recommending maintenance of pharmacological treatment at maximum tolerated doses [9, 264]
We strictly forbid the utilization of any form of watermark or intellectual property mark on images posted on our platform
On Ozempic (semaglutide 0.5-2.0 mg, primarily for Type 2 diabetes management): A February 2026 study published in the Journal of Clinical Endocrinology & Metabolism (Kasher Meron et al.) examined fragility fracture rates in adults aged 65 and older with Type 2 diabetes who started GLP-1 medications versus those taking other diabetes medications
One gummy, 13 powerful nutrients for head-to-toe support
(2) Spread beyond the skin
Not for use by individuals on MAOIs, SSRIs, or other contraindicated medications